Together, these findings indicate that down-regulation of PD-L1 N-linked glycosylation was connected to inhibition of STAT3 and STAT1 activation (noted in MCF-7 cells), and to reduced cell-autonomous and PD-1-induced tumor cell invasion and release of pro-tumorigenic factors in breast cancer cells. The gene discussed is STAT1; the disease is breast carcinoma.